A detailed history of Eagle Asset Management Inc transactions in Nuvalent, Inc. stock. As of the latest transaction made, Eagle Asset Management Inc holds 130,770 shares of NUVL stock, worth $10.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
130,770
Previous 155,949 16.15%
Holding current value
$10.6 Million
Previous $11.8 Million 13.08%
% of portfolio
0.08%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$67.44 - $112.17 $1.7 Million - $2.82 Million
-25,179 Reduced 16.15%
130,770 $13.4 Million
Q2 2024

Aug 12, 2024

SELL
$62.76 - $81.61 $1.74 Million - $2.26 Million
-27,696 Reduced 15.08%
155,949 $11.8 Million
Q1 2024

May 09, 2024

BUY
$72.35 - $88.99 $13.3 Million - $16.3 Million
183,645 New
183,645 $13.8 Million

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.49B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.